Displaying 1 - 1 of 1
| Active Ingredient | OCTREOTIDE |
| Therapeutic Class | OTHER THERAPEUTIC AGENTS |
| Indications | Symptomatic management of neuroendocrine tumours. |
| Caution | Anorexia, nausea, vomiting, diarrhoea and steatorrhoea, abdominal discomfort, and flatulence. |
| Dose Range | Initially 50 micrograms 1–2 times a day , adjusted according to resp onse; increased to 200 micrograms 3 times a day. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |